UniProtKB/Swiss-Prot P00439 : Variant p.Arg252Trp
Phenylalanine-4-hydroxylase
Gene: PAH
Feedback ?
Variant information
Variant position:
252
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LP/P [Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Arginine (R) to Tryptophan (W) at position 252 (R252W, p.Arg252Trp).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from large size and basic (R) to large size and aromatic (W)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
-3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In PAH deficiency; severe; haplotypes 1,6,7,8,42, 69; complete loss of activity.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
252
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
452
The length of the canonical sequence.
Location on the sequence:
QFLQTCTGFRLRPVAGLLSS
R DFLGGLAFRVFHCTQYIRHG
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human QFLQTCTGFRLRPVAGLLSSR DFLGGLAFRVFHCTQYIRHG
Mouse QFLQTCTGFRLRPVAGLLSSR DFLGGLAFRVFHCTQYIRHG
Rat QFLQTCTGFRLRPVAGLLSSR DFLGGLAFRVFHCTQYIRHG
Bovine QFLQSCTGFRLRPVAGLLSSR DFLGGLAFRVFHCTQYIRHG
Caenorhabditis elegans DFLKDCTGYTIRPVAGLLSSR DFLAGLAFRVFHSTQYIRHH
Drosophila NFLRDCTGFTLRPVAGLLSSR DFLAGLAFRVFHSTQYIRHP
Slime mold NFLQECTGWRIRPVQGLLSAR DFLNGLAFRVFHATQYIRHP
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 452
Phenylalanine-4-hydroxylase
Helix
251 – 259
Literature citations
Phenylketonuria missense mutations in the Mediterranean.
Okano Y.; Wang T.; Eisensmith R.C.; Longhi R.; Riva E.; Giovannini M.; Cerone R.; Romano C.; Woo S.L.C.;
Genomics 9:96-103(1991)
Cited for: VARIANTS PAH DEFICIENCY TRP-252 AND LEU-281;
Prediction of multiple hypermutable codons in the human PAH gene: codon 280 contains recurrent mutations in Quebec and other populations.
Byck S.; Tyfield L.; Carter K.; Scriver C.R.;
Hum. Mutat. 9:316-321(1997)
Cited for: VARIANTS PAH DEFICIENCY; VARIANTS PAH DEFICIENCY GLN-158; TRP-158; LEU-176; PRO-176; ILE-230; CYS-241; HIS-241; LEU-241; GLN-243; GLN-252; GLY-252; TRP-252; GLN-261; PRO-261; LYS-280; LEU-281; CYS-297; HIS-297; THR-322; MET-380; LEU-388; MET-388; GLN-408; TRP-408; PRO-413; SER-413 AND ASN-415;
Phenylketonuria and hyperphenylalaninemia in eastern Germany: a characteristic molecular profile and 15 novel mutations.
Hennermann J.B.; Vetter B.; Wolf C.; Windt E.; Buehrdel P.; Seidel J.; Moench E.; Kulozik A.E.;
Hum. Mutat. 15:254-260(2000)
Cited for: VARIANTS PAH DEFICIENCY LEU-20; LEU-39; PRO-41; SER-48; LEU-55; THR-65; SER-68; TYR-84; ASP-104; CYS-110; PRO-155; GLN-158; GLN-183; ALA-190; THR-211; ILE-230; PHE-231; GLN-243; ALA-245; TRP-252; GLN-261; LEU-281; CYS-299; SER-300; VAL-306; VAL-309; CYS-325; ASP-330; ARG-344; VAL-344; VAL-348; PRO-349; CYS-386; GLY-390; PRO-395; VAL-403; TRP-408; SER-410 AND CYS-414;
A phenylalanine hydroxylase amino acid polymorphism with implications for molecular diagnostics.
Gjetting T.; Romstad A.; Haavik J.; Knappskog P.M.; Acosta A.X.; Silva W.A. Jr.; Zago M.A.; Guldberg P.; Guettler F.;
Mol. Genet. Metab. 73:280-284(2001)
Cited for: VARIANTS PAH DEFICIENCY TRP-252 AND THR-318; VARIANT GLU-274;
Mutation analysis in Hyperphenylalaninemia patients from South Italy.
Trunzo R.; Santacroce R.; D'Andrea G.; Longo V.; De Girolamo G.; Dimatteo C.; Leccese A.; Lillo V.; Papadia F.; Margaglione M.;
Clin. Biochem. 46:1896-1898(2013)
Cited for: VARIANTS PAH DEFICIENCY PHE-39 DEL; VAL-65; LEU-121; TYR-196; TYR-201; ILE-230; TRP-252; GLN-261; SER-300; VAL-306; MET-380; GLY-390; VAL-403 AND TRP-408;
Five novel mutations and two large deletions in a population analysis of the phenylalanine hydroxylase gene.
Groselj U.; Tansek M.Z.; Kovac J.; Hovnik T.; Podkrajsek K.T.; Battelino T.;
Mol. Genet. Metab. 106:142-148(2012)
Cited for: VARIANTS PAH DEFICIENCY ALA-45; SER-48; PRO-62; SER-157; GLN-158; LEU-177; GLY-178; ALA-190; HIS-226; ALA-245; TRP-252; GLN-261; LYS-280; LEU-281; SER-300; PRO-349; GLY-390; VAL-403; TRP-408 AND ASN-415;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.